BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17583450)

  • 1. Characterization and compaction behaviour of nimesulide crystal forms.
    Di Martino P; Censi R; Barthélémy C; Gobetto R; Joiris E; Masic A; Odou P; Martelli S
    Int J Pharm; 2007 Sep; 342(1-2):137-44. PubMed ID: 17583450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical characterization and dissolution properties of nimesulide-cyclodextrin binary systems.
    Nalluri BN; Chowdary KP; Murthy KV; Hayman AR; Becket G
    AAPS PharmSciTech; 2003; 4(1):E2. PubMed ID: 12916912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
    Park HJ; Kim MS; Lee S; Kim JS; Woo JS; Park JS; Hwang SJ
    Int J Pharm; 2007 Jan; 328(2):152-60. PubMed ID: 16959448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of process variables on physicomechanical properties of the agglomerates obtained by spherical crystallization technique.
    Maghsoodi M
    Pharm Dev Technol; 2011 Oct; 16(5):474-82. PubMed ID: 20557281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supercritical antisolvent precipitation of nimesulide: preliminary experiments.
    Moneghini M; Perissutti B; Vecchione F; Kikic I; Alessi P; Cortesi A; Princivalle F
    Curr Drug Deliv; 2007 Jul; 4(3):241-8. PubMed ID: 17627498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of a new polymorphic form and a solvate of glibenclamide.
    Hassan MA; Sheikh Salem M; Sallam E; al-Hindawi MK
    Acta Pharm Hung; 1997; 67(2-3):81-8. PubMed ID: 9223758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a drug with wax-like properties as a melt binder.
    Dhumal RS; Shimpi SL; Chauhan B; Mahadik KR; Paradkar A
    Acta Pharm; 2006 Dec; 56(4):451-61. PubMed ID: 19839137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour.
    Lai F; Sinico C; Ennas G; Marongiu F; Marongiu G; Fadda AM
    Int J Pharm; 2009 May; 373(1-2):124-32. PubMed ID: 19429297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A material-sparing method for simultaneous determination of true density and powder compaction properties--aspartame as an example.
    Sun CC
    Int J Pharm; 2006 Dec; 326(1-2):94-9. PubMed ID: 16926076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid state investigation and characterization of the polymorphic and pseudopolymorphic forms of indapamide.
    Ghugare P; Dongre V; Karmuse P; Rana R; Singh D; Kumar A; Filmwala Z
    J Pharm Biomed Anal; 2010 Feb; 51(3):532-40. PubMed ID: 19796901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallization of a non-steroidal anti-inflammatory drug from ethanol-water solution in presence of polymers: physicochemical characterization and release behaviour from suppositories.
    Mallick S; Dey PK; Sannigrahi S; Mitra A
    Acta Pol Pharm; 2004; 61(6):447-53. PubMed ID: 15794337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of solvatomorphs of methotrexate using thermoanalytical and other techniques.
    Chadha R; Arora P; Kaur R; Saini A; Singla ML; Jain DS
    Acta Pharm; 2009 Sep; 59(3):245-57. PubMed ID: 19819822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of dry granulation on compactibility and capping tendency of macrolide antibiotic formulation.
    Bozic DZ; Dreu R; Vrecer F
    Int J Pharm; 2008 Jun; 357(1-2):44-54. PubMed ID: 18308490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Crystalline polymorphism of eflucimibe].
    Ribet JP; Pena R; Chauvet A; Patoiseau JF; Autin JM; Segonds R; Basquin M; Autret JM
    Ann Pharm Fr; 2002 May; 60(3):177-86. PubMed ID: 12050596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal forms of tolbutamide from acetonitrile and 1-octanol: effect of solvent, humidity and compression pressure.
    Chakravarty P; Alexander KS; Riga AT; Chatterjee K
    Int J Pharm; 2005 Jan; 288(2):335-48. PubMed ID: 15620874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of nimesulide containing nanocrystal formulations.
    Gülsün T; Budak C; Vural I; Sahin S; Öner L
    Pharm Dev Technol; 2013; 18(3):653-9. PubMed ID: 22375930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method.
    Li XS; Wang JX; Shen ZG; Zhang PY; Chen JF; Yun J
    Int J Pharm; 2007 Sep; 342(1-2):26-32. PubMed ID: 17566675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone.
    da Silva AA; de Matos JR; Formariz TP; Rossanezi G; Scarpa MV; do Egito ES; de Oliveira AG
    Int J Pharm; 2009 Feb; 368(1-2):45-55. PubMed ID: 18992313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tableting and tablet properties of alginates: characterisation and potential for Soft Tableting.
    Schmid W; Picker-Freyer KM
    Eur J Pharm Biopharm; 2009 May; 72(1):165-72. PubMed ID: 18992337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.